Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
| 1) | Registration Statement (Form S-3, No. 333-280310) of Century Therapeutics, Inc., |
| 2) | Registration Statement (Form S-3, No. 333-279422) of Century Therapeutics, Inc., |
| 3) | Registration Statement (Form S-8, No. 333-277930) pertaining to the 2021 Equity Incentive Plan of Century Therapeutics, Inc., |
| 4) | Registration Statement (Form S-8 No. 333-270649) pertaining to the 2021 Equity Incentive Plan of Century Therapeutics, Inc., |
| 5) | Registration Statement (Form S-8 No. 333-263666) pertaining to the 2021 Equity Incentive Plan and 2021 Employee Stock Purchase Plan of Century Therapeutics, Inc., |
| 6) | Registration Statement (Form S-8 No. 333-257644) pertaining to the 2018 Stock Option and Grant Plan, 2021 Equity Incentive Plan, and the 2021 Employee Stock Purchase Plan of Century Therapeutics, Inc., |
| 7) | Registration Statement (Form S-8 No. 333-285936) pertaining to the 2021 Equity Incentive Plan of Century Therapeutics, Inc. |
| 8) | Registration Statement (Form S-3 No. 333-288616) of Century Therapeutics, Inc. |
| 9) | Registration Statement (Form S-3 No. 333-293228) of Century Therapeutics, Inc. |
of our report dated March 12, 2026, with respect to the consolidated financial statements of Century Therapeutics, Inc. included in this Annual Report (Form 10-K) of Century Therapeutics, Inc. for the year ended December 31, 2025.
/s/ Ernst & Young LLP
Philadelphia, Pennsylvania
March 12, 2026